Deferoxamine

vascular endothelial growth factor A ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35045699 Angiogenesis Promotion by Combined Administration of DFO and Vein Endothelial Cells Using Injectable, Biodegradable, Nanocomposite Hydrogel Scaffolds. 2022 Feb 21 4
2 35066024 Calcium ion cross-linked sodium alginate hydrogels containing deferoxamine and copper nanoparticles for diabetic wound healing. 2022 Mar 31 1
3 33613246 Desferrioxamine-Related Pseudo-Vitelliform Dystrophy and the Effect of Anti-Vascular Endothelial Growth Factor. 2021 Jan-Apr 3
4 34150058 Deferoxamine enhances the migration of dental pulp cells via hypoxia-inducible factor 1α. 2021 3
5 34636157 Electrospun Fibers Improving Cellular Respiration via Mitochondrial Protection. 2021 Nov 2
6 32418841 Deferoxamine enhances the regenerative potential of diabetic Adipose Derived Stem Cells. 2020 Sep 1
7 32815062 Comparison the effects of hypoxia-mimicking agents on migration-related signaling pathways in mesenchymal stem cells. 2020 Dec 1
8 31803431 An open-space microfluidic chip with fluid walls for online detection of VEGF via rolling circle amplification. 2019 Oct 7 2
9 28419698 Collagen barrier membranes do not adsorb hypoxia mimetic activity-Activity of gingival fibroblasts cultured directly on collagen barrier membranes loaded with hypoxia mimetic agents. 2018 Feb 1
10 30113159 Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing. 2018 Sep 12 3
11 30250985 Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells. 2018 Nov 1
12 30305827 Hypoxic stabilization of mRNA is HIF-independent but requires mtROS. 2018 1
13 27773752 A stimuli responsive liposome loaded hydrogel provides flexible on-demand release of therapeutic agents. 2017 Jan 15 2
14 23897831 Pharmacological priming of adipose-derived stem cells for paracrine VEGF production with deferoxamine. 2016 Mar 6
15 27936076 Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2. 2016 2
16 26304864 Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways. 2015 Sep 1
17 24610641 PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells. 2014 Nov 1
18 21885032 PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells. 2012 Jan 1
19 22562065 Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. 2012 Jul 10 2
20 21187066 NF-κB suppresses HIF-1α response by competing for P300 binding. 2011 Jan 28 1
21 20645943 Beneficial effects of desferrioxamine on encapsulated human islets--in vitro and in vivo study. 2010 Sep 1
22 22993609 Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells. 2010 Sep 4
23 18371939 Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain. 2008 May 1 1
24 18512268 Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells. 2008 Jul 1
25 17204543 Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling. 2007 Apr 2
26 17257889 Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma. 2007 Jul 2
27 15885310 Vascular endothelial growth factor is regulated by hypoxic stress via MAPK and HIF-1 alpha in the inner ear. 2005 Jun 3
28 8706019 Up-regulation of vascular endothelial growth factor production by iron chelators. 1996 Aug 15 3